Home > Insider Trading > Filing (0001062993-22-014506)

Filing Details

Accession Number:: 0001062993-22-014506
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-08 19:11:07
Reporting Period:: 2022-06-06

Accepted Time:: 2022-06-08 19:11:07
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1661181	Organogenesis Holdings Inc.	ORGO	Biological Products, (No Disgnostic Substances) (2836)	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1074084	Albert Erani	C/O Rugby Realty Co., Inc. 300 Lighting Way, Ste 210 Secaucus NJ 07094	No	No	Yes	No
1244191	H Glenn Nussdorf	35 Sawgrass Drive Bellport NY 11713	Yes	No	Yes	No
1757286	A. Alan Ades	C/O Rugby Realty Co., Inc. 300 Lighting Way Secaucus NJ 07094	Yes	No	Yes	No
1757453	Gn 2016 Family Trust U/A/D August 12, 2016	35 Sawgrass Drive Bellport NY 11713	No	No	Yes	No
1757455	12/20/12 Dated Trust Issue 2012 Erani Dennis	6000 Island Boulevard Apt. 2502 Aventura FL 33160	No	No	Yes	No
1757567	Grat 2014 Ades Alan	C/O Rugby Realty Co., Inc. 300 Lighting Way Secaucus NJ 07094	No	No	Yes	No
1757573	Organo Investors Llc	C/O Rugby Realty Co., Inc. 300 Lighting Way Secaucus NJ 07094	No	No	Yes	No
1757580	Organo Pfg Llc	C/O Rugby Realty Co., Inc. 300 Lighting Way Secaucus NJ 07094	No	No	Yes	No
1760663	12/29/2012 Dated Trust Family Erani Albert	C/O Rugby Realty Co., Inc. 300 Lighting Way, Ste 210 Secaucus NJ 07094	No	No	Yes	No
1760694	Starr Wisdom	44 Wilson Street Hartsdale NY 10530	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Disposition	2022-06-06	100,000	$5.41	59,348,027	No	4	S	Direct
Class A Common Stock	Disposition	2022-06-07	50,000	$5.49	59,298,027	No	4	S	Direct
Class A Common Stock	Disposition	2022-06-08	20,000	$5.39	59,278,027	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.55, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.33 to $5.54, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.34 to $5.49, inclusive. The reporting person undertakes to provide to Organogenesis, any security holder of Organogenesis, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.
Reflects the total number of securities held by the Group. Only Albert Erani has a pecuniary interest in the shares being sold pursuant to this Form 4. None of the other members of the Group has a pecuniary interest in the shares being sold pursuant to this Form 4.